Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person ramosetron [cytosol]

Class:Id	ChemicalDrug:9648941
_displayName	ramosetron [cytosol]
_timestamp	2020-10-27 16:16:08
compartment	[Compartment:70101] cytosol
created	[InstanceEdit:9648932] Jassal, Bijay, 2019-06-10
disease	[Disease:9656389] nausea [Disease:9696492] vomiting
literatureReference	[LiteratureReference:9648936] Evaluation of the pharmacological profile of ramosetron, a novel therapeutic agent for irritable bowel syndrome [LiteratureReference:9649137] Ramosetron, a 5-HT3 receptor antagonist for the control of nausea and vomiting [LiteratureReference:9649153] The clinical potential of ramosetron in the treatment of irritable bowel syndrome with diarrhea (IBS-D)
modified	[InstanceEdit:9649865] Jassal, Bijay, 2019-06-17 [InstanceEdit:9705635] Jassal, Bijay, 2020-10-27
name	ramosetron
referenceEntity	[ReferenceTherapeutic:9648942] ramosetron [Guide to Pharmacology:2301]
stableIdentifier	[StableIdentifier:9648970] R-ALL-9648941.1
(hasMember)	[DefinedSet:9648956] HTR3A antagonists [cytosol]
[Change default viewing format]

No pathways have been reviewed or authored by ramosetron [cytosol] (9648941)